casemark/drafting-equity-offering-prospectuses

Drafting Equity Offering Prospectuses

Structures S-1/F-1 prospectus content including business description, risk factors, MD&A, use of proceeds, dilution analysis, and financial statement presentation for SEC-registered equity offerings.

When To Use

• Preparing an initial S-1 or F-1 registration statement for an IPO
• Drafting amendments (S-1/A) in response to SEC comment letters
• Structuring prospectus content for follow-on offerings (S-1 shelf takedowns)
• Building risk factor or MD&A sections for equity offering documents
• Reviewing prospectus drafts for completeness against Regulation S-K requirements

Inputs To Gather

• Company information: Business description, corporate history, organizational structure, subsidiaries, and jurisdiction of incorporation
• Financial statements: Audited financials for the required periods (typically 2–3 fiscal years plus interim periods), auditor identity and independence status [VERIFY period requirements based on EGC status and FPI status]
• Offering terms: Shares offered (primary vs. secondary), anticipated price range, underwriter names and roles, greenshoe/overallotment option size
• Capitalization data: Pre- and post-offering cap table, outstanding options/warrants/convertibles, authorized share count
• Risk factor inventory: Company-specific risks, industry risks, regulatory risks, offering-specific risks (dilution, no prior market, lock-up expiration)
• MD&A source materials: Management narrative on results of operations, liquidity, capital resources, known trends, critical accounting estimates
• Use of proceeds: Specific allocation of net proceeds (debt repayment, working capital, acquisitions, R&D) with dollar amounts or percentages where available
• Related-party transactions: Any transactions with directors, officers, or 5%+ holders requiring Item 404 disclosure
• Lock-up terms: Duration, parties subject, any early release triggers [VERIFY against underwriting agreement]

Workflow

1. Determine registration form and disclosure regime

   • Confirm S-1 (domestic) vs. F-1 (foreign private issuer)
   • Assess Emerging Growth Company (EGC) status and available accommodations (reduced financial history, no Say-on-Pay, deferred XBRL) [VERIFY EGC revenue threshold — currently $1.235B]
   • Identify any Smaller Reporting Company (SRC) scaled disclosure eligibility
   • Confirm applicable Regulation S-K items and Industry Guide requirements (e.g., Guide 7 for mining, Guide 3 for banking) [VERIFY industry-specific guides]

2. Build prospectus skeleton per Part I of Form S-1

   • Front cover: Offering summary, share/price information, underwriter table, SEC legend
   • Prospectus summary: Business overview, the offering (structured table), summary financial data
   • Risk factors: Organized by category (company, industry, regulatory, offering-related); lead with most material risks
   • Use of proceeds: Specific allocations; if general corporate purposes, disclose principal purposes
   • Dividend policy: Historical dividend information and forward-looking policy
   • Capitalization: Pre-offering and as-adjusted columns; footnote option/warrant impact
   • Dilution: Net tangible book value per share before and after offering; dilution to new investors table
   • MD&A: Period-over-period analysis, segment discussion if applicable, liquidity and capital resources, contractual obligations table, critical accounting policies
   • Business: Full description per Item 101 — history, products/services, customers, competition, IP, regulation, employees, properties
   • Management: Directors and executive officers, compensation discussion (or scaled if EGC), equity compensation plans
   • Related-party transactions: Item 404 disclosure with approval procedures
   • Principal stockholders: Beneficial ownership table (pre- and post-offering)
   • Description of capital stock: Rights, preferences, anti-takeover provisions, transfer agent
   • Underwriting: Compensation, stabilization, lock-ups, indemnification summary
   • Legal matters / Experts: Counsel and auditor identification
   • Financial statements: Placed at back of prospectus with auditor report

3. Draft risk factors

   • Start with company-specific operational and financial risks
   • Follow with industry and market risks
   • Include regulatory and legal compliance risks
   • End with offering-specific risks (no prior public market, price volatility, dilution from future issuances, lock-up expiration impact)
   • Each risk factor: specific heading stating the risk → explanatory narrative → potential consequence to investor
   • Avoid generic/boilerplate language that invites SEC comments; tie each risk to company-specific facts

4. Draft MD&A

   • Cover each income statement period presented with year-over-year or sequential comparison
   • Quantify drivers of revenue and expense changes (volume, price, mix, acquisitions)
   • Discuss known trends, demands, commitments, events, or uncertainties (Item 303)
   • Address liquidity: cash position, operating cash flow trends, credit facility availability, anticipated capital expenditures
   • Disclose critical accounting estimates with sensitivity analysis where material
   • For EGCs electing extended transition period, note GAAP adoption timeline [VERIFY election status]

5. Prepare financial presentation components

   • Summary selected financial data table (if required — SRCs and EGCs may omit) [VERIFY]
   • Capitalization table with clear column headers (Actual / Pro Forma / Pro Forma As Adjusted)
   • Dilution table computing net tangible book value per share
   • Contractual obligations table in MD&A (operating leases, debt maturities, purchase obligations)

6. Review and refine

   • Cross-check all financial figures against audited statements and cap table
   • Verify internal consistency (share counts, percentages, dollar amounts across sections)
   • Confirm all Item requirements of the applicable form are addressed
   • Flag any missing exhibits or consents for Part II

Output

A structured prospectus draft (or specified sections) containing:

• Properly sequenced disclosure sections per Form S-1/F-1
• Company-specific risk factors organized by materiality and category
• Quantitative MD&A with period-over-period analysis
• Capitalization and dilution tables with pre/post-offering columns
• Bracketed placeholders for terms pending pricing (e.g., [●] shares, $[●] per share)
• [VERIFY] flags on jurisdiction-dependent items, financial thresholds, and regulatory citations

Quality Checks

• [ ] All Regulation S-K line items applicable to the form are addressed or consciously omitted with rationale
• [ ] Risk factors are company-specific, not generic boilerplate; each tied to disclosed facts
• [ ] MD&A covers every period for which financial statements are presented
• [ ] Capitalization and dilution math is internally consistent and ties to financial statements
• [ ] Use of proceeds totals match net proceeds estimate (after underwriting discount and expenses)
• [ ] EGC / SRC accommodations are correctly applied and disclosed on cover page [VERIFY]
• [ ] Related-party transactions include all persons within Item 404 scope
• [ ] Beneficial ownership table uses correct SEC methodology (options exercisable within 60 days)
• [ ] No forward-looking statements without appropriate safe harbor language (noting PSLRA safe harbor is unavailable for IPOs) [VERIFY]
• [ ] All bracketed/placeholder terms ([●]) are cataloged for completion at pricing